Cancer-related deaths in India are projected to go up by 20% over the next four years.
Shukrit Sudhir Chimote
Chief Executive Officer, Sayre Therapeutics
Shukrit&nbsp;has had a proven track record in the Pharmaceutical Industry and prior to co-founding Sayre Therapeutics, he served as Vice-President and India &amp; South Asia Head, Branded Formulations at a premier Indian biotech. In his earlier roles at the Indian biotech, he has headed the Novel Medicines out-licensing and Biosimilars’ strategic business units. Prior to this role,&nbsp;Shukrit&nbsp;was employed with Bristol-Myers Squibb, Princeton, NJ, US in roles within the Anti-infectives, Cardiology and Immunology franchises. He was part of the global marketing team where he conceptualized the go-to-market strategies for Japan, China, Singapore and Indian markets, among other Asia-Pacific markets. Shukrit&nbsp;completed his Bachelor’s degree in Pharmacy from Mumbai, India and his MS in Pharmacology &amp; an MBA in Pharmaceutical Marketing from the University of Mississippi, US. He also has a Masters in International affairs from the Columbia University, New York.
SIGN UP FOR THE DAILY BRIEF FROM HUFFPOST INDIA